Regen BioPharma Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
David Koos
Chief Executive Officer (CEO)
US$10.1k
Compensación total
| Porcentaje del salario del CEO | 100.0% |
| Permanencia del CEO | 3.1yrs |
| Participación del CEO | 0.01% |
| Permanencia media de la dirección | sin datos |
| Promedio de permanencia en la Junta Directiva | 8.8yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -US$775k |
| Sep 30 2023 | US$10k | US$10k | US$1m |
| Jun 30 2023 | n/a | n/a | US$1m |
| Mar 31 2023 | n/a | n/a | US$68m |
| Dec 31 2022 | n/a | n/a | US$1m |
| Sep 30 2022 | n/a | n/a | US$2m |
| Jun 30 2022 | n/a | n/a | US$910k |
| Mar 31 2022 | n/a | n/a | -US$67m |
| Dec 31 2021 | n/a | n/a | -US$6m |
| Sep 30 2021 | US$1 | n/a | -US$7m |
| Jun 30 2021 | n/a | n/a | -US$4m |
| Mar 31 2021 | n/a | n/a | US$6m |
| Dec 31 2020 | n/a | n/a | US$2m |
| Sep 30 2020 | n/a | n/a | US$3m |
| Jun 30 2020 | n/a | n/a | US$4m |
| Mar 31 2020 | n/a | n/a | -US$4m |
| Dec 31 2019 | n/a | n/a | -US$454k |
| Sep 30 2019 | US$54k | US$54k | -US$3m |
| Jun 30 2019 | n/a | n/a | -US$5m |
| Mar 31 2019 | n/a | n/a | -US$887k |
| Dec 31 2018 | n/a | n/a | -US$2m |
| Sep 30 2018 | US$180k | US$180k | -US$5m |
| Jun 30 2018 | n/a | n/a | -US$5m |
| Mar 31 2018 | n/a | n/a | -US$8m |
| Dec 31 2017 | n/a | n/a | -US$8m |
| Sep 30 2017 | US$181k | US$175k | -US$6m |
Compensación vs. Mercado: David($USD10.05K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD740.57K).
Compensación vs. Ingresos: La compensación de David ha aumentado mientras la empresa no es rentable.
CEO
David Koos (62 yo)
3.1yrs
Permanencia
US$10,050
Compensación
Dr. David Raymond Koos, Ph D., DBA., served as Chairman of the Board of Directors, Chief Executive Officer, President, Secretary and Treasurer at SYBLEU INC. Dr. Koos serves as Chairman, CEO, President, Se...
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman | 3.1yrs | US$10.05k | 0.012% $ 319.9 | |
| Member of Scientific Advisory Board | 9.5yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 1.3yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 11.9yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 10.6yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 8.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 8.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 8.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 8.8yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 8.7yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 8.5yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | 1.3yrs | sin datos | sin datos |
8.8yrs
Permanencia media
Junta con experiencia: La junta directiva de RGBP se considera experimentada (8.4 años de antigüedad promedio).